276.07 USD
+1.98
0.72%
At close Updated Sep 17, 4:00 PM EDT
Pre-market
After hours
276.07
0.00
0%
1 day
0.72%
5 days
0.8%
1 month
2.06%
3 months
6.41%
6 months
14.82%
Year to date
20.98%
1 year
21.61%
5 years
75.54%
10 years
166.79%
 

About: Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Employees: 70,000

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

32% more call options, than puts

Call options by funds: $79.4M | Put options by funds: $60.2M

18% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 90

17% more capital invested

Capital invested by funds: $17.9B [Q1] → $21B (+$3.11B) [Q2]

3.74% more ownership

Funds ownership: 91.79% [Q1] → 95.53% (+3.74%) [Q2]

0% more funds holding

Funds holding: 959 [Q1] → 959 (+0) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 13 [Q1] → 13 (+0) [Q2]

6% less repeat investments, than reductions

Existing positions increased: 337 | Existing positions reduced: 357

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$275
0% upside
Avg. target
$300
9% upside
High target
$310
12% upside

6 analyst ratings

positive
83%
neutral
17%
negative
0%
Truist Securities
David Macdonald
$310
Buy
Maintained
25 Jul 2025
UBS
Kevin Caliendo
$305
Buy
Maintained
25 Jul 2025
Evercore ISI Group
Elizabeth Anderson
$300
Outperform
Maintained
25 Jul 2025
Morgan Stanley
Ricky Goldwasser
$306
Overweight
Maintained
25 Jul 2025
Baird
Eric Coldwell
$302
Outperform
Maintained
25 Jul 2025

Financial journalist opinion

Based on 11 articles about LH published over the past 30 days

Positive
Zacks Investment Research
7 hours ago
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Labcorp's $225M acquisition of BioReference Health select assets boosts its oncology diagnostics portfolio and expands patient access nationwide.
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Positive
Zacks Investment Research
yesterday
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Labcorp Holdings (LH) is a Strong Growth Stock
Neutral
PRNewsWire
2 days ago
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
BURLINGTON, N.C. and MIAMI , Sept.
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Neutral
Seeking Alpha
8 days ago
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Labcorp Holdings Inc. (NYSE:LH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Adam Schechter - President, CEO & Chairman Julia Wang - CFO & Executive VP Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good morning, everyone. I'm Erin Wright, health care services analyst at Morgan Stanley.
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Positive
Zacks Investment Research
14 days ago
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Neutral
PRNewsWire
21 days ago
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
BURLINGTON, N.C. , Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, Sept.
Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
Negative
Zacks Investment Research
22 days ago
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
LH witnesses growth in specialty testing and strategic acquisitions, but macro and currency headwinds remain a concern.
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
Positive
Zacks Investment Research
28 days ago
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Positive
Zacks Investment Research
29 days ago
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
Positive
Zacks Investment Research
29 days ago
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
Charts implemented using Lightweight Charts™